Know Cancer

or
forgot password

Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive


N/A
19 Years
N/A
Open (Enrolling)
Both
Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer, Gastrointestinal Carcinoma, Pancreatic Carcinoma, Lung Cancer, Esophageal Carcinoma

Thank you

Trial Information

Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive


Inclusion Criteria:



- Patients must meet one (or more) of the following criteria:

- Preoperative diagnosis of ovarian, fallopian tube, or primary peritoneal carcinoma
(all stage, grade and histology)

- Preoperative diagnosis of grade III endometrial carcinoma (all stage, all histology)

- Preoperative diagnosis of uterine serous carcinoma (all stage, all grade)

- Preoperative diagnosis of clear cell endometrial carcinoma (all stage, all grade)

- Preoperative diagnosis of endometrial carcinosarcoma (all stage, all grade)

- Gastrointestinal carcinoma (all histology, stage and grade)

- Pancreatic carcinoma (all histology, stage and grade)

- Lung cancer (all histology, stage and grade)

- Esophageal carcinoma (all histology, stage and grade)

- Suspected or pathologically confirmed metastatic disease to the lung (all disease
primaries)

- Suspected or pathologically confirmed malignant pleural effusion (all disease
primaries)

Patients must meet all of the following criteria:

- Planned thorascopic robotic or laparoscopic surgical approach

- >18 years old

- Not pregnant

- Able to give consent Participation in other research protocols does not exclude a
patient from participation in this study.

Exclusion Criteria:

- None

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Determine the feasibility of Narrow Band Imaging (NBI) at the time of thorascopic, laparoscopic or robotic surgery.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Nadeem Abu-Rustum, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

10-180

NCT ID:

NCT01262040

Start Date:

December 2010

Completion Date:

December 2013

Related Keywords:

  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Peritoneal Cancer
  • Gastrointestinal Carcinoma
  • Pancreatic Carcinoma
  • Lung Cancer
  • Esophageal Carcinoma
  • NBI
  • ENDOMETRIUM
  • FALLOPIAN TUBE
  • OVARY
  • PERITONEUM
  • Surgery
  • Lung
  • Pancreatic
  • Esophageal
  • thorascopic
  • laparoscopic
  • robotic
  • 10-180
  • Carcinoma
  • Endometrial Neoplasms
  • Esophageal Diseases
  • Esophageal Neoplasms
  • Lung Neoplasms
  • Ovarian Neoplasms
  • Pancreatic Neoplasms
  • Rectal Neoplasms
  • Duodenal Neoplasms
  • Bile Duct Neoplasms
  • Peritoneal Neoplasms
  • Fallopian Tube Neoplasms
  • Adenoma

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021